Li Hua Zheng
Oprichter bij AnHeart Therapeutics (Hangzhou) Co., Ltd.
Actieve functies van Li Hua Zheng
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
AnHeart Therapeutics (Hangzhou) Co., Ltd.
 AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Directeur/Bestuurslid | 27-11-2018 | - |
| Oprichter | 27-11-2018 | - | |
| Corporate Officer/Principal | 27-11-2018 | - | |
| Anbio, Inc. | Directeur/Bestuurslid | 01-12-2017 | - |
| Oprichter | 01-12-2017 | - | |
| Zheng & Karg LLP | Corporate Officer/Principal | 01-01-2018 | - |
Loopbaan van Li Hua Zheng
Eerdere bekende functies van Li Hua Zheng
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| Liu, Zheng, Chen & Hoffman LLP | Corporate Officer/Principal | 01-10-2015 | 01-12-2017 |
| UCOMMUNE INTERNATIONAL LTD | Directeur/Bestuurslid | 01-12-2018 | - |
| Independent Dir/Board Member | 01-12-2018 | - |
Opleiding van Li Hua Zheng
| Fordham University School of Law | Graduate Degree |
| Baylor College of Medicine | Doctorate Degree |
| Fudan University | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 7 |
| China | 3 |
Operationeel
| Corporate Officer/Principal | 3 |
| Director/Board Member | 3 |
| Graduate Degree | 2 |
Sectoraal
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Orisun Acquisition Corp.
 Orisun Acquisition Corp. Financial ConglomeratesFinance Orisun Acquisition Corp. is a blank check company, which engages in the provision of merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, with one or more target businesses. The company was founded on October 22, 2018 and is headquartered in New York, NY. | Finance |
AnHeart Therapeutics (Hangzhou) Co., Ltd.
AnHeart Therapeutics (Hangzhou) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services AnHeart Therapeutics (Hangzhou) Co., Ltd. engages in the development of pharmaceutical products. Its offers neurotrophic tyrosine receptor kinase and c-ros oncogene 1 dual-target inhibitors for cancer treatment. The company was founded by Jun Yuan Wang, Bing Yan and Li Hua Zheng on November 27, 2018 and is headquartered in Hangzhou, China. | Commercial Services |
| Anbio, Inc. | |
| Zheng & Karg LLP | |
| Liu, Zheng, Chen & Hoffman LLP |
- Beurs
- Insiders
- Li Hua Zheng
- Ervaring
